Bvf Inc Axsome Therapeutics, Inc. Transaction History

Bvf Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $8.61 Million - $12.5 Million	-150,000 Reduced 7.04%	1,981,100 $158 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $22 Million - $28.2 Million	376,100 Added 21.43%	2,131,100 $131 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $70.1 Million - $140 Million	1,755,000 New	1,755,000 $135 Million

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.38B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.